Sierra Oncology, Inc. (SRRA)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD

Add to watchlist

16.94-0.64 (-3.64%)

At close: 4:00PM EDT

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Neutralpattern detected

All

CNW Group
Sierra Oncology Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
, March 23, 2021 /CNW/ - Sierra Oncology, Inc. (SRRA), a late-stage biopharmaceutical company on a quest to deliver targeted therapies that treat rare forms of cancer, granted a stock option to a new employee as approved by the Compensation Committee of the Company's Board of Directors, under Sierra Oncology's 2018 Equity Inducement Plan.
Simply Wall St.
Here's What Sierra Oncology, Inc.'s (NASDAQ:SRRA) Shareholder Ownership Structure Looks Like
A look at the shareholders of Sierra Oncology, Inc. ( NASDAQ:SRRA ) can tell us which group is most powerful. Insiders...
PR Newswire
Sierra Oncology Reports 2020 Year End Results
Sierra Oncology, Inc. (SRRA), a late-stage biopharmaceutical company on a quest to deliver targeted therapies that treat rare forms of cancer, today reported its financial and operational results for the fourth quarter and fiscal year ended December 31, 2020.